Join your peers to celebrate the start of the Regional Chain Conference.

Commence the conference with presentations from industry leaders and experts so you can stay ahead of pharmacy and retail trends. 

This session explores the transformation from traditional reimbursement models to cost-based frameworks, driven by regulatory momentum, government mandates, and market demand. We will examine how evolving benchmarks, acquisition-cost methodologies, and compliance requirements are reshaping pharmacy economics.

This presentation examines the Inflation Reduction Act (IRA) and its quantitative impact on retail pharmacies, with a focus on drug price negotiations, Maximum Fair Prices (MFPs), and resulting cash-flow and working-capital pressures. Leveraging Inmar Intelligence data across 35 pharmacy chains, it illustrates how IRA-designated drugs will represent a growing share of sales while extending receivable timelines and increasing operational complexity. The presentation also includes an overview on the Drug Supply Chain Security Act (DSCSA), summarizing the impact to date on dispensers, including interoperability readiness, exception handling, and ongoing compliance challenges since the November 27, 2025 final milestone.

Join your industry peers to recap on the day’s sessions and establish new connections.

Appointment-driven one-to-one business meetings between chain executives and key supplier trading partners set the stage for developing profitable marketing ideas and strengthening existing relationships.

Conclude Regional Chain by connecting with new and existing business partners while enjoying a grand assortment of cuisine prepared throughout the evening.